New CREDENCE Data Support SGLT2 Inhibitor Use in Advanced CKD ...Middle East

Medscape - News
'We would not recommend initiating treatment with SGLT2 inhibitor in eGFR < 30 until results of the other pending trials are available,' but new CREDENCE data add to the evidence base, say investigators. Medscape Medical News

Hence then, the article about new credence data support sglt2 inhibitor use in advanced ckd was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New CREDENCE Data Support SGLT2 Inhibitor Use in Advanced CKD )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News